The dual ( ETA and ETB ) endothelin receptor antagonist bosentan ( marketed as Tracleer ) was approved in 2001 .
The dual ( ETA and ETB ) endothelin receptor antagonist bosentan ( marketed as Tracleer ® ) was approved in 2001 .